Reports
Sale
Global Recombinant Protein Market Size, Share, Forecast: By Product Type: Growth Factor and Cytokines, Hormone, Enzyme, Antibody, Immune Checkpoint Proteins, Recombinant Regulatory Proteins, Others; By Application: Therapeutic, Research, Biotechnology Industry; Regional Analysis; Supplier Landscape; 2024-2032
Global Recombinant Protein Market Size
The global recombinant protein market was valued at USD 1.9 billion in 2023, driven by the increasing demand for effective drugs to treat chronic diseases across the globe. The market is expected to grow at a CAGR of 11.21% during the forecast period of 2024 and 2032, likely to attain a value of USD 5 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Recombinant Protein Market Outlook
- The market growth is expected to grow in value due to the increasing demand for effective and efficient drugs for improved treatment of patients. The development of such drugs has been sped up due to the creation of various effective recombinant protein-based vaccines created for COVID-19.
- The rising prevalence of chronic illness is likely to enhance the demand for recombinant protein therapies due to their effectiveness in treating such diseases. The market is expected to expand further with the growing number of cancer cases.
- With the rising demand for effective drugs for specific diseases, key players and government agencies are increasingly investing in the development of novel drugs, which is expected to propel the market development further.
Global Recombinant Protein Market Overview
Recombinant proteins are synthesized using recombinant DNA methods, where a new gene sequence is produced and the coded protein is inserted into host organism such as bacteria, yeast, or animal cells to produce the protein. It involves gene cloning and transformation. It enables selection, expression, purification and study of the protein. Recombinant proteins are vital in medicine (for instance, insulin and monoclonal antibodies), research, industry, and agriculture because their quality is standardized, the expression level can be easily scaled up and fine-tuned according to the needs. In addition, the production can be customized depending on the specific application. It offers advantages like purity and offers advantages like cost efficiency, making it ideal for mass production.
Global Recombinant Protein Market Growth Drivers
Increased Application in Disease Management
Diseases like cerebral apoplexy, multiple sclerosis, neutropenia, and thrombocytopenia are becoming more common, boosting the demand for recombinant proteins. Cancer is a highly common and fast-growing chronic disease among the major chronic diseases. The American Cancer Society (ACS) analysis from 2023 projected 1,958,310 and 609,820 deaths in United States, requiring effective and precise treatment alternatives to combat the condition. Recombinant proteins are also used in the treatments like such as chemotherapy, cell culture, western blot, animal cell culture, glycosylation, biotherapeutic products, and bioengineering, thereby, boosting the global market value.
Surge in Partnerships Between Leading Players to Meet Rising Recombinant Protein Market Demand
In January 2024, Nucleus Biologics, a top cell culture media provider, entered a deal with Core Biogenesis to distribute and manufacture affordable and sustainable recombinant proteins. Together, the two companies aim to work together and deliver better, cheaper reagents and media to the cell and gene therapy markets. As per the terms of agreement, Nucleus Biologics will act as a GMP manufacturer for Core Biogenesis’ recombinant proteins. Such partnerships are expected to shape the market landscape effectively, as it works to provide precise and affordable solutions to consumers.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Recombinant Protein Market Trends
| Key Trends | Impact |
| Focus on Personalized Medicine | The use of recombinant proteins is evolving the treatment of patients, along with the possibility of creating unique therapies. These proteins are critical in developing therapies based on genetic makeup, notably in cancer and inherited metabolic diseases. The special accuracy of recombinant proteins in such applications is not only more effective in the treatment of disease but also decreases the side effects of the therapy, making it safer and more effective. |
| Adoption of Agricultural Biotechnology | These recombinant proteins are used in agricultural biotechnology as well. These proteins play a significant role in creating desirable transgenic crops characterized by resistance to pests, diseases, and drought, besides boosting their nutritional value. Recombinant proteins are also playing a role in the development of bio-pesticides and bio-fertilizers for sustainable agriculture and raising crop productivity. |
| Increased Collaborations and Partnerships | Strategic collaborations and partnerships assuming greater significance in the recombinant protein market, intended to foster innovation. The biotechnology firms are collaborating to capitalize on synergistic capabilities, exchange new technologies, and accelerate development programs. They provide new access to markets, research, and development relief, as well as innovation. |
Global Recombinant Protein Market Segmentation
Market Breakup by Product Type
- Growth Factor and Cytokines
- Hormone
- Enzyme
- Antibody
- Immune Checkpoint Proteins
- Recombinant Regulatory Proteins
- Others
Market Breakup by Application
- Therapeutic
- Research
- Biotechnology Industry
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Recombinant Protein Market Share
Hormones Lead the Market Based on Product Type
Based on product type, the market can be divided into growth factor and cytokines, hormones, enzymes, antibodies, immune checkpoint proteins, and recombinant regulatory proteins, among others. The hormones segment is likely to take lead, owing to its versatility, particularly in the areas of research and innovation, including the development of therapies for diseases including diabetes. Hormones are very essential in the body involved in treatment for various diseases. Moreover, ease of intake makes it a popular alternative amongst users, affecting the market dynamics significantly.
Biotechnology Industry is Anticipated to Have Largest Market Share Based on Application
Based on application, the market is divided into therapeutic, research, biotechnology Industry. Among these biotechnology industry is expected to hold a significant market share, as it widely applies recombinant proteins at the clinical stages of designing, testing, and manufacturing new drugs. Recombinant proteins are central to the development of biopharmaceuticals and translate research successes into production that is clinically scalable.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Recombinant Protein Market Analysis by Region
Various regions covered in the global market report include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Based on the regional analysis, North America is projected to hold largest market share in the forecast period, driven by increasing prevalence of diseases like cancer, diabetes, cardiovascular diseases, chronic respiratory diseases, among others. Growth in research and development activities between key market stakeholders and governments to meet the rising need for efficient medicine and treatment is also play a critical role in boosting market value.
The Asia Pacific region is likely to grow at a faster rate, owing to factors such as increasing healthcare expenditure, the growing biotechnology sector, and the upsurge in interest in recombinant protein therapies. For instance, in May 2023, Thermo Fisher Scientific Inc., and National Research and Innovation Agency (BRIN) entered the Memorandum of Understanding (MOU) with the aim of strengthening the Indonesian research and innovation systems and capacities. The partnership was aimed at helping and supporting country-level research and innovation institutions and their capacities towards improving scientific activity and the Indonesian economy. The collaboration can be viewed as a move towards enhancing the capacity of Indonesia to contribute and advance in the global realm of research and innovation.
Leading Players in the Global Recombinant Protein Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis along with strategic initiatives by the key players. The major companies in the market are as follows:
Abcam PLC
Founded in 1998, this company occupies a premier position in the market dealing in protein research tools. The specific areas of expertise crafted by the company include primary antibodies and secondary antibodies, proteins and peptides, knockout cell lines and lysates, and cell and tissue imaging reagents, among others.
Thermo Fisher Scientific, Inc.,
Known as one of the largest biotechnology research companies, it is based in Massachusetts, United States. The company operates in different sectors, which include analytical instruments, lab supply chain services and e-business solutions, general lab equipment and services, specialty diagnostics, life science records, pharma solutions, contract development, and manufacturing organization.
Bio-Techne Corp.
This United States based company is a provider of purified proteins and reagent solutions to customers in pharmaceuticals and other specialty markets. It is also involved in protein analysis solutions, like analyzing solutions services and produces antibodies, enzymes, proteins, cell culture reagents, and others.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is a leading global pharmaceutical firm with a functional base in Basel, Switzerland; the firm operates in recombinant proteins, among many others. It works in different therapeutic segments, which include oncology, immunology, and infectious disease.
Other companies in the market include Abbott, Merck KGaA, Bio-Rad Laboratories, Inc., GeneTex, Inc, Lonza Group SA, PerkinElmer Inc., Sino Biological Inc., TAKARA HOLDINGS INC., Tosoh Corporation, XENOTECH AI Pvt Ltd., and NEW ENGLAND BIOLABS, INC.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Recombinant Protein Market Report Snapshots
Recombinant Protein Market Size
Recombinant Protein Market Growth
Recombinant Protein Market Trends
Recombinant Protein Market Share
Recombinant Protein Regional Analysis
Key Questions Answered in the Recombinant Protein Market Report
- What was the global recombinant protein market value in 2023?
- What is the global recombinant protein market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on product types?
- What is the market breakup based on application?
- What are the major factors aiding the global recombinant protein market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major global recombinant protein market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the recombinant protein market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
- What are the key challenges faced by biotechnology companies in producing recombinant proteins?
- What factors are driving the growth of the recombinant protein market in North America?
- What technological advancements are driving innovation in the recombinant protein market?
- How are global regulatory frameworks affecting the production and distribution of recombinant proteins?
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Recombinant Protein Market Overview
3.1 Global Recombinant Protein Market Historical Value (2017-2023)
3.2 Global Recombinant Protein Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Recombinant Protein Market Landscape*
5.1 Global Recombinant Protein: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Recombinant Protein: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Vector
5.2.3 Analysis Application
5.2.4 Analysis by Cell type
6 Global Recombinant Protein Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Recombinant Protein Market Segmentation (2017-2032)
7.1 Global Recombinant Protein Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Growth Factor and Cytokines
7.1.3 Hormone
7.1.4 Enzyme
7.1.5 Antibody
7.1.6 Immune Checkpoint Proteins
7.1.7 Recombinant Regulatory Proteins
7.1.8 Others
7.2 Global Recombinant Protein Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Therapeutic
7.2.3 Research
7.2.4 Biotechnology Industry
7.3 Global Recombinant Protein Market (2017-2032) by Region
7.3.1 Market Overview
7.3.2 North America
7.3.3 Europe
7.3.4 Asia Pacific
7.3.5 Latin America
7.3.6 Middle East and Africa
8 North America Recombinant Protein Market (2017-2032)
8.1 North America Recombinant Protein Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Growth Factor and Cytokines
8.1.3 Hormone
8.1.4 Enzyme
8.1.5 Antibody
8.1.6 Immune Checkpoint Proteins
8.1.7 Recombinant Regulatory Proteins
8.1.8 Others
8.2 North America Recombinant Protein Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Therapeutic
8.2.3 Research
8.2.4 Biotechnology Industry
8.3 North America Recombinant Protein Market (2017-2032) by Country
8.3.1 United States of America
8.3.2 Canada
9 Europe Recombinant Protein Market (2017-2032)
9.1 Europe Recombinant Protein Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Growth Factor and Cytokines
9.1.3 Hormone
9.1.4 Enzyme
9.1.5 Antibody
9.1.6 Immune Checkpoint Proteins
9.1.7 Recombinant Regulatory Proteins
9.1.8 Others
9.2 Europe Recombinant Protein Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Therapeutic
9.2.3 Research
9.2.4 Biotechnology Industry
9.3 Europe Recombinant Protein Market (2017-2032) by Country
9.3.1 United Kingdom
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Others
10 Asia Pacific Recombinant Protein Market (2017-2032)
10.1 Asia Pacific Recombinant Protein Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Growth Factor and Cytokines
10.1.3 Hormone
10.1.4 Enzyme
10.1.5 Antibody
10.1.6 Immune Checkpoint Proteins
10.1.7 Recombinant Regulatory Proteins
10.1.8 Others
10.2 Asia Pacific Recombinant Protein Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Therapeutic
10.2.3 Research
10.2.4 Biotechnology Industry
10.3 Asia Pacific Recombinant Protein Market (2017-2032) by Country
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 ASEAN
10.3.5 Australia
10.3.6 Others
11 Latin America Recombinant Protein Market (2017-2032)
11.1 Latin America Recombinant Protein Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Growth Factor and Cytokines
11.1.3 Hormone
11.1.4 Enzyme
11.1.5 Antibody
11.1.6 Immune Checkpoint Proteins
11.1.7 Recombinant Regulatory Proteins
11.1.8 Others
11.2 Latin America Recombinant Protein Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Therapeutic
11.2.3 Research
11.2.4 Biotechnology Industry
11.3 Latin America Recombinant Protein Market (2017-2032) by Country
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Mexico
11.3.4 Others
12 Middle East and Africa Recombinant Protein Market (2017-2032)
12.1 Middle East and Africa Recombinant Protein Market (2017-2032) by Product Type
12.1.1 Market Overview
12.1.2 Growth Factor and Cytokines
12.1.3 Hormone
12.1.4 Enzyme
12.1.5 Antibody
12.1.6 Immune Checkpoint Proteins
12.1.7 Recombinant Regulatory Proteins
12.1.8 Others
12.2 Middle East and Africa Recombinant Protein Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Therapeutic
12.2.3 Research
12.2.4 Biotechnology Industry
12.3 Middle East and Africa Recombinant Protein Market (2017-2032) by Country
12.3.1 Saudi Arabia
12.3.2 United Arab Emirates
12.3.3 Nigeria
12.3.4 South Africa
12.3.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Clinical Trial Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Grant Analysis
16.1 Analysis by Year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Product
16.5 Analysis by Funding Institute
16.6 Analysis by Departments
16.7 Analysis by Recipient Organization
17 Funding and Investment Analysis
17.1 Analysis by Funding Instances
17.2 Analysis by Type of Funding
17.3 Analysis by Funding Amount
17.4 Analysis by Leading Players
17.5 Analysis by Leading Investors
17.6 Analysis by Geography
18 Strategic Initiative
18.1 Analysis by Partnership Instances
18.2 Analysis by Type of Partnership
18.3 Analysis by Leading Players
18.4 Analysis by Geography
19 Supplier Landscape
19.1 Market Share Analysis, By Region (Top 5 Companies)
19.1.1 Market Share Analysis: Global
19.1.2 Market Share Analysis: North America
19.1.3 Market Share Analysis: Europe
19.1.4 Market Share Analysis: Asia-Pacific
19.1.5 Market Share Analysis: Others
19.2 Abbott
19.2.1 Financial Analysis
19.2.2 Product Portfolio
19.2.3 Demographic Reach and Achievements
19.2.4 Mergers and Acquisitions
19.2.5 Certifications
19.3 Abcam PLC
19.3.1 Financial Analysis
19.3.2 Product Portfolio
19.3.3 Demographic Reach and Achievements
19.3.4 Mergers and Acquisitions
19.3.5 Certifications
19.4 Thermo Fisher Scientific, Inc .
19.4.1 Financial Analysis
19.4.2 Product Portfolio
19.4.3 Demographic Reach and Achievements
19.4.4 Mergers and Acquisitions
19.4.5 Certifications
19.5 Bio-Techne Corp .
19.5.1 Financial Analysis
19.5.2 Product Portfolio
19.5.3 Demographic Reach and Achievements
19.5.4 Mergers and Acquisitions
19.5.5 Certifications
19.6 Merck KGaA
19.6.1 Financial Analysis
19.6.2 Product Portfolio
19.6.3 Demographic Reach and Achievements
19.6.4 Mergers and Acquisitions
19.6.5 Certifications
19.7 Bio-Rad Laboratories, Inc .
19.7.1 Financial Analysis
19.7.2 Product Portfolio
19.7.3 Demographic Reach and Achievements
19.7.4 Mergers and Acquisitions
19.7.5 Certifications
19.8 GeneTex, Inc
19.8.1 Financial Analysis
19.8.2 Product Portfolio
19.8.3 Demographic Reach and Achievements
19.8.4 Mergers and Acquisitions
19.8.5 Certifications
19.9 Lonza Group SA
19.9.1 Financial Analysis
19.9.2 Product Portfolio
19.9.3 Demographic Reach and Achievements
19.9.4 Mergers and Acquisitions
19.9.5 Certifications
19.10 F. Hoffmann-La Roche Ltd .
19.10.1 Financial Analysis
19.10.2 Product Portfolio
19.10.3 Demographic Reach and Achievements
19.10.4 Mergers and Acquisitions
19.10.5 Certifications
19.11 PerkinElmer Inc .
19.11.1 Financial Analysis
19.11.2 Product Portfolio
19.11.3 Demographic
19.11.4 Mergers and Acquisitions
19.11.5 Certifications
19.12 Sino Biological Inc .
19.12.1 Financial Analysis
19.12.2 Product Portfolio
19.12.3 Demographic Reach and Achievements
19.12.4 Mergers and Acquisitions
19.12.5 Certifications
19.13 TAKARA HOLDINGS INC .
19.13.1 Financial Analysis
19.13.2 Product Portfolio
19.13.3 Demographic Reach and Achievements
19.13.4 Mergers and Acquisitions
19.13.5 Certifications
19.14 Tosoh Corporation
19.14.1 Financial Analysis
19.14.2 Product Portfolio
19.14.3 Demographic Reach and Achievements
19.14.4 Mergers and Acquisitions
19.14.5 Certifications
19.15 XENOTECH AI Pvt Ltd .
19.15.1 Financial Analysis
19.15.2 Product Portfolio
19.15.3 Demographic Reach and Achievements
19.15.4 Mergers and Acquisitions
19.15.5 Certifications
19.16 NEW ENGLAND BIOLABS, INC
19.16.1 Financial Analysis
19.16.2 Product Portfolio
19.16.3 Demographic Reach and Achievements
19.16.4 Mergers and Acquisitions
19.16.5 Certifications
20 Recombinant Protein Market – Distribution Model (Additional Insight)
20.1 Overview
20.2 Potential Distributors
20.3 Key Parameters for Distribution Partner Assessment
21 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive, moreover we can provide analysis of companies as per custom request.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER